These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 39136778)
1. Exploring novel drug targets for atopic dermatitis through plasma proteome with genome. Wu W; Su H; Chen Z; Wei S Arch Dermatol Res; 2024 Aug; 316(8):521. PubMed ID: 39136778 [TBL] [Abstract][Full Text] [Related]
2. Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study. Niu Q; Zhang T; Mao R; Zhao N; Deng S Sci Rep; 2024 Aug; 14(1):18097. PubMed ID: 39103489 [TBL] [Abstract][Full Text] [Related]
3. Plasma proteins and inflammatory dermatoses: proteome-wide Mendelian randomization and colocalization analyses. Liu M; Chen M; Tan J; Chen A; Guo J Arch Dermatol Res; 2024 Jul; 316(7):443. PubMed ID: 38951247 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction. Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297 [TBL] [Abstract][Full Text] [Related]
5. Identification of plasma protein markers of allergic disease risk: a mendelian randomization approach to proteomic analysis. Cao Z; Li Q; Li Y; Wu J BMC Genomics; 2024 May; 25(1):503. PubMed ID: 38773393 [TBL] [Abstract][Full Text] [Related]
6. Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications. Wang L; Guo X; Qin J; Jin Z; Liu Q; Sun C; Sun K; Li L; Wei X; Zhang Y Osteoporos Int; 2024 Nov; 35(11):1973-1987. PubMed ID: 39120624 [TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease. Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome. Sun J; Zhao J; Jiang F; Wang L; Xiao Q; Han F; Chen J; Yuan S; Wei J; Larsson SC; Zhang H; Dunlop MG; Farrington SM; Ding K; Theodoratou E; Li X Genome Med; 2023 Sep; 15(1):75. PubMed ID: 37726845 [TBL] [Abstract][Full Text] [Related]
9. Investigating potential novel therapeutic targets and biomarkers for ankylosing spondylitis using plasma protein screening. You W; Lin Y; Liu M; Lin Z; Ye R; Zhang C; Zeng R Front Immunol; 2024; 15():1406041. PubMed ID: 39185422 [TBL] [Abstract][Full Text] [Related]
10. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers. Zhang Y; Liu W; Lai J; Zeng H Front Immunol; 2024; 15():1394438. PubMed ID: 38835753 [TBL] [Abstract][Full Text] [Related]
11. PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses. Han QJ; Zhu YP; Sun J; Ding XY; Wang X; Zhang QZ Front Pharmacol; 2024; 15():1418560. PubMed ID: 39035989 [TBL] [Abstract][Full Text] [Related]
12. Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study. Zhao H; Zhou Y; Wang Z; Zhang X; Chen L; Hong Z Front Immunol; 2024; 15():1417564. PubMed ID: 39026678 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel drug targets for multiple sclerosis by integrating plasma genetics and proteomes. Liu Y; Wang Q; Zhao Y; Liu L; Hu J; Qiao Y; Chen J; Qin C Exp Gerontol; 2024 Sep; 194():112505. PubMed ID: 38964432 [TBL] [Abstract][Full Text] [Related]
14. Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study. Wang H; Pang J; Zhou Y; Qi Q; Tang Y; Gul S; Sheng M; Dan J; Tang W Clin Transl Allergy; 2024 Apr; 14(4):e12350. PubMed ID: 38573314 [TBL] [Abstract][Full Text] [Related]
15. Genetic support for the causal association between 91 circulating inflammatory proteins and atopic dermatitis: A two-sample Mendelian randomization trial. Du X; Shi H; Liu X; Wang Y; Du T; Wang P; Cheng L; Zhu J; Li F Skin Res Technol; 2024 Aug; 30(8):e13872. PubMed ID: 39081133 [TBL] [Abstract][Full Text] [Related]
16. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma. Zhang L; Xiong Y; Zhang J; Feng Y; Xu A J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019 [TBL] [Abstract][Full Text] [Related]
17. Identification of drug targets for Sjögren's syndrome: multi-omics Mendelian randomization and colocalization analyses. Bai Y; Wang J; Feng X; Xie L; Qin S; Ma G; Zhang F Front Immunol; 2024; 15():1419363. PubMed ID: 38933282 [TBL] [Abstract][Full Text] [Related]
18. Exploring causal correlations between circulating cytokines and atopic dermatitis: a bidirectional two-sample Mendelian randomization study. Xuan Z; Chen X; Zhou W; Shen Y; Sun Z; Zhang H; Yao Z Front Immunol; 2024; 15():1367958. PubMed ID: 39055710 [TBL] [Abstract][Full Text] [Related]
19. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis. Zou M; Shao Z Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773 [TBL] [Abstract][Full Text] [Related]
20. Proteomic Mendelian randomization to identify protein biomarkers of telomere length. Zhao J; Yang K; Lu Y; Zhou L; Fu H; Feng J; Wu J Sci Rep; 2024 Sep; 14(1):21594. PubMed ID: 39284832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]